PTGX EBITDA | Protagonist Therapeutics, Inc

Protagonist Therapeutics, Inc (PTGX) EBITDA

2026-06-30: Basis Reported; EBITDA $159.16M*; Operating income $158.77M; Depreciation and amortization $397.00K*.
2026-03-31: Basis Reported; EBITDA -$3.24M; Operating income (m); Depreciation and amortization (m).
2025-12-31: Basis Reported; EBITDA -$49.98M; Operating income (m); Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA -$46.06M*; Operating income -$46.42M; Depreciation and amortization $361.00K*.

Complete source-backed ebitda history.

Available history: 2014-12-31 to 2026-03-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	$159.16M*	$158.77M	$397.00K*	$213.47M	74.56%*	$168.00K*	$219.05M*	(m)	$42.06M	(m)	$2.27M
2026-03-31	Reported	-$3.24M	(m)	(m)	(m)	-5.75%	$215.00K	-$48.94M	(m)	$46.74M	(m)	-$1.50M
2025-12-31	Reported	-$49.98M	(m)	(m)	(m)	-672.03%	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-30	Reported	-$46.06M*	-$46.42M	$361.00K*	(m)	(m)	$88.00K*	-$1.94M*	(m)	$40.00M	(m)	$0.00
2025-06-30	Reported	-$41.74M*	-$42.04M	$304.00K*	$5.55M	-752.56%*	$813.00K*	-$28.78M*	(m)	$37.04M	(m)	$172.00K
2025-03-31	Reported	-$19.07M	(m)	(m)	(m)	-67.34%	$545.00K	$125.36M	(m)	$35.89M	(m)	$0.00
2024-12-31	Reported	$126.9M	(m)	(m)	(m)	74.37%	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-30	Reported	-$41.22M*	-$41.45M	$231.00K*	(m)	(m)	$775.00K*	-$27.86M*	(m)	$35.97M	(m)	-$420.00K
2024-06-30	Reported	-$38.55M*	-$38.79M	$241.00K*	(m)	(m)	$28.00K*	$268.62M*	(m)	$33.52M	(m)	-$676.00K
2024-03-31	Reported	$206.55M	(m)	(m)	(m)	81.01%	$242.00K	-$27.43M	(m)	$33.73M	(m)	$3.33M
2023-12-31	Reported	$23.3M	(m)	(m)	(m)	38.83%	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	Reported	-$38.08M*	-$38.33M	$244.00K*	(m)	(m)	$404.00K*	-$26.61M*	(m)	$30.66M	(m)	$0.00
2023-06-30	Reported	-$42.12M*	-$42.35M	$237.00K*	(m)	(m)	$176.00K*	-$26.24M*	(m)	$33.18M	(m)	$0.00
2023-03-31	Reported	-$35.77M	(m)	(m)	(m)	(m)	$10.00K	-$34.35M	(m)	$27.42M	(m)	$0.00
2022-12-31	Reported	-$36.26M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Reported	-$32.03M*	-$32.30M	$270.00K*	(m)	(m)	$162.00K*	-$25.20M*	(m)	$25.40M	(m)	(m)
2022-06-30	Reported	-$41.18M*	-$41.44M	$259.00K*	(m)	(m)	$290.00K*	-$13.63M*	(m)	$34.61M	(m)	(m)
2022-03-31	Reported	-$20.86M	(m)	(m)	(m)	-81.11%	$273.00K	-$37.67M	(m)	$36.32M	(m)	(m)
2021-09-30	Reported	(m)	-$33.93M	(m)	(m)	(m)	$265.00K*	-$28.47M*	(m)	$36.96M	(m)	$0.00
2021-06-30	Reported	-$30.70M*	-$30.88M	$185.00K*	(m)	(m)	$500.00K*	-$23.70M*	(m)	$26.43M	(m)	$0.00
2021-03-31	Reported	-$23.84M	(m)	(m)	(m)	-385.22%	$140.00K	-$28.76M	(m)	$24.25M	(m)	$0.00
2020-12-31	Reported	-$18.48M	(m)	(m)	(m)	-327.13%	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Reported	-$7.59M*	-$7.77M	$182.00K*	(m)	(m)	$75.00K*	-$16.29M*	(m)	$15.99M	(m)	$0.00
2020-06-30	Reported	-$18.02M*	-$18.22M	$202.00K*	(m)	(m)	$133.00K*	-$21.48M*	(m)	$20.26M	(m)	$1.13M
2020-03-31	Reported	-$19.48M	(m)	(m)	(m)	(m)	$138.00K	-$15.85M	(m)	$18.77M	(m)	$176.00K
2019-12-31	Reported	-$17.07M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Reported	-$16.97M*	-$17.17M	$195.00K*	(m)	(m)	-$309.00K*	-$14.25M*	(m)	$17.29M	(m)	-$102.00K
2019-06-30	Reported	-$31.23M*	-$31.41M	$176.00K*	(m)	(m)	$892.00K*	$3.67M*	(m)	$19.36M	(m)	-$1.63M
2019-03-31	Reported	-$14.52M	(m)	(m)	(m)	-930.64%	$166.00K	-$16.66M	(m)	$12.44M	(m)	$183.00K
2018-12-31	Reported	-$15.28M	(m)	(m)	(m)	-649.55%	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Reported	-$9.24M*	-$9.39M	$151.00K*	(m)	(m)	$148.00K*	-$9.28M*	(m)	$12.14M	(m)	$0.00
2018-06-30	Reported	-$9.07M*	-$9.24M	$170.00K*	(m)	(m)	$68.00K*	-$15.40M*	(m)	$17.73M	(m)	$0.00
2018-03-31	Reported	-$8.15M	(m)	(m)	(m)	-75.61%	$208.00K	-$15.14M	(m)	$15.37M	(m)	$0.00
2017-12-31	Reported	-$3.4M	(m)	(m)	(m)	-30.10%	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Reported	-$4.87M*	-$4.98M	$108.00K*	(m)	(m)	$190.00K*	$40.70M*	(m)	$11.17M	(m)	(m)
2017-06-30	Reported	-$15.04M*	-$15.13M	$93.00K*	(m)	(m)	$372.00K*	-$12.33M*	(m)	$12.01M	(m)	(m)
2017-03-31	Reported	-$14.19M	(m)	(m)	(m)	(m)	$48.00K	-$10.36M	(m)	$11.28M	(m)	(m)
2016-12-31	Reported	-$11.32M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Reported	-$7.05M*	-$7.14M	$83.00K*	(m)	(m)	$16.00K*	(m)	(m)	$5.56M	(m)	(m)
2016-06-30	Reported	-$7.00M*	-$7.09M	$86.00K*	(m)	(m)	$28.00K*	(m)	(m)	$5.70M	(m)	(m)
2016-03-31	Reported	-$6.97M	(m)	(m)	(m)	(m)	$251.00K	(m)	(m)	$5.63M	(m)	(m)
2015-12-31	Reported	-$4.91M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Reported	-$3.97M*	-$4.02M	$49.00K*	(m)	(m)	$113.00K*	(m)	(m)	$3.16M	(m)	(m)
2015-06-30	Reported	(m)	-$3.08M	(m)	(m)	(m)	(m)	(m)	(m)	$2.30M	(m)	(m)
2015-03-31	Reported	(m)	-$2.69M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	-$156.85M	(m)	(m)	(m)	-340.85%	$1.59M	$57.67M	(m)	$159.29M	(m)	$838.00K
2024-12-31	Reported	$253.67M	(m)	(m)	(m)	58.39%	$1.35M	$184.15M	(m)	$138.13M	(m)	$4.22M
2023-12-31	Reported	-$92.68M	(m)	(m)	(m)	-154.46%	$609.00K	-$70.24M	(m)	$120.16M	(m)	$0.00
2022-12-31	Reported	-$130.34M	(m)	(m)	(m)	-490.35%	$795.00K	-$108.14M	(m)	$126.22M	(m)	$0.00
2021-12-31	Reported	-$125.03M	(m)	(m)	(m)	-457.04%	$1.10M	-$107.86M	(m)	$126.01M	(m)	$0.00
2020-12-31	Reported	-$63.57M	(m)	(m)	(m)	-222.05%	$471.00K	-$72.48M	(m)	$74.51M	(m)	$1.30M
2020-09-30	Rolling	(m)	-$62.98M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-06-30	Rolling	(m)	-$72.38M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-03-31	Rolling	(m)	-$85.57M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-12-31	Reported	-$79.79M	(m)	(m)	(m)	-34540.69%	$967.00K	-$41.53M	(m)	$65.00M	(m)	-$691.00K
2019-12-31	Rolling	(m)	-$80.52M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Rolling	(m)	-$78.63M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-06-30	Rolling	(m)	-$70.86M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-03-31	Rolling	(m)	-$48.69M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-12-31	Reported	-$41.74M	(m)	(m)	(m)	-134.98%	$486.00K	-$49.95M	(m)	$59.50M	(m)	-$799.00K
2018-12-31	Rolling	(m)	-$42.27M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Rolling	(m)	-$30.37M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-06-30	Rolling	(m)	-$25.96M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-03-31	Rolling	(m)	-$31.85M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-12-31	Reported	-$37.49M	(m)	(m)	(m)	-186.87%	$666.00K	$3.87M	(m)	$46.18M	(m)	$0.00
2017-12-31	Rolling	(m)	-$37.90M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Rolling	(m)	-$45.78M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-06-30	Rolling	(m)	-$47.94M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-03-31	Rolling	(m)	-$39.90M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-12-31	Reported	-$32.35M	(m)	(m)	(m)	(m)	$347.00K	-$29.97M	(m)	$25.70M	(m)	$0.00
2016-12-31	Rolling	(m)	-$32.67M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Rolling	(m)	-$26.27M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-06-30	Rolling	(m)	-$23.15M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-03-31	Rolling	(m)	-$19.14M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-12-31	Reported	-$14.55M	(m)	(m)	(m)	(m)	$399.00K	-$14.38M	(m)	$11.83M	(m)	$0.00
2015-12-31	Rolling	(m)	-$14.79M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-12-31	Reported	-$9.06M	(m)	(m)	(m)	(m)	$299.00K	(m)	(m)	$7.46M	(m)	$0.00

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
TG THERAPEUTICS, INC. (TGTX)	United States	$8.805B	19.05
CYTOKINETICS INC (CYTK)	United States	$9.130B	-11.86
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)	United States	$9.331B	-42.28
Praxis Precision Medicines, Inc. (PRAX)	United States	$7.884B	-27.60
Structure Therapeutics Inc. (GPCR)	United States	$7.710B	-53.41
Spyre Therapeutics, Inc. (SYRE)	United States	$7.685B	-43.69
Axsome Therapeutics, Inc. (AXSM)	United States	$10.274B	-66.82
IONIS PHARMACEUTICALS INC (IONS)	United States	$7.277B	-23.25
Alkermes plc. (ALKS)		$6.844B	132.74
RHYTHM PHARMACEUTICALS, INC. (RYTM)	United States	$6.771B	-37.20